Virtu KCG Holdings’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Virtu KCG Holdings’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$30K	Buy	18,295 +13,346	+270%	+$29.9K	﹤0.01%	2685
2017 Q1	$17K	Sell	4,949 -28,956	-85%	-$137K	﹤0.01%	2991
2016 Q4	$176K	Buy	33,905 +31,133	+1,123%	+$539K	﹤0.01%	2668
2016 Q3	$70K	Buy	+2,772	New	+$69.9K	﹤0.01%	2727
2015 Q1	–	Sell	-4,387	Closed	-$55K	–	4211
2014 Q4	$55K	Buy	+4,387	New	+$63.7K	﹤0.01%	3412
2014 Q1	–	Sell	-2,224	Closed	-$54K	–	4342
2013 Q4	$54K	Buy	+2,224	New	+$57.3K	﹤0.01%	3586

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Virtu KCG Holdings's ANTH Position: Q2 2017 in Review

Virtu KCG Holdings increased its Anthera Pharmaceuticals, Inc. (ANTH) stake by 270% in Q2 2017, buying an estimated $29.9K and bringing the position to 18,295 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

Virtu KCG Holdings first reported a position in ANTH in Q4 2013 and has held it in 6 quarters since. The position peaked at $176K in Q4 2016. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

Virtu KCG Holdings held 18,295 shares of Anthera Pharmaceuticals, Inc. worth $30K as of Q2 2017.
Virtu KCG Holdings bought 13,346 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $29.9K.
Anthera Pharmaceuticals, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2685 holding.
Virtu KCG Holdings first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2013 and has held it in 6 quarters since.
Virtu KCG Holdings's Anthera Pharmaceuticals, Inc. position peaked at $176K in Q4 2016.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.